Skip to main content

Table 1 The follow-up observation indicators of the patient

From: Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months

Parameters

First admission

Discharge

First review

Second review

Third review

Forth review

10 Feb

18 Feb

4 Mar

19 Mar

20 Apr

18 May

white blood count(3.5–9.5) x109/L

4.7

6.23

5.76

6.34

8.86

10.71

neutrophils (2–7) x109/L

3.26

3.67

3.35

3.89

5.44

6.47

lymphocyte (0.8–4) x109/L

1.12

1.98

1.93

1.94

2.84

3.78

hemoglobin (110-160 g/L)

117

114

133

146

133

143

platelet count (100–300) x109/L

121

192

45

15

62

68

Albumin (35-55 g/L)

36.6

35.6

45.3

53.5

41.6

42.1

globulin (20-35 g/L)

26.1

24.1

31.4

35.7

24.2

20.8

Alanine aminotransferase (> 37 U/L)

16

17

30

48

19

22

Aspartate aminotransferase (> 37 U/L)

20

20

25

42

17

20

Total bilirubin(> 20.5umol/L)

2.8

4.4

10.3

12.1

9.6

8.2

Creatinine (40-133umol/L)

46

59

53

53

62

61

Lactate dehydrogenase (109-245 U/L)

214

158

159

203

156

216

creatine kinase (25-196 U/L)

44

59

41

46

20

32

D-dimer (0-1μg/ml)

1.22

NA

0.66

0.56

0.43

0.49

Fibrinogen (0-5μg/ml)

4.1

NA

2.2

1.7

1.6

NA

C-reactive protein (0-5 mg/L)

86.34

1.3

0.83

1.29

< 0.8

0.83

SAA (0-10 mg/L)

> 320

18.08

< 4.8

< 4.8

< 4.8

4.93

Procalcitonin> = 0.5 ng/ml

0.051

NA

NA

NA

NA

NA

Lymphocyte subsets (cells/ul)

 CD3 + T cells (770–2041)

736

1459

1285

1018

1654

2897

 CD4 + T cells (414–1123)

490

905

734

588

1163

1710

 CD8 + T cells (238–874)

212

434

412

346

415

936

 CD4/CD8

2.31

2.09

1.78

1.7

2.8

1.83

 CD19 + B cells (90–560)

129

125

166

126

372

370

 CD56 + NK cells (150–1100)

45

227

208

249

150

302

nucleic acid of SARS-CoV-2 (+/−)

+

–

–

–

–

–

Change of the chest CT

Ab

S

S

S

S

N

Novel coronavirus specific antibody

 IgG (+/−)

NA

NA

NA

NA

+

+

 IgM (+/−)

NA

NA

NA

NA

–

–

  1. The follow up of laboratory indicators were in this table from the first admission, mainly including the peripheral blood count, biochemistry indicators, lymphocytes and the result of nucleic acid for SARS-CoV-2. the follow-up was carried out every 15 days after the first discharge.
  2. + positive, - negative, NA no available, SAA serum amyloid A, Ab abnormal, S stable or absorption